300725 药石科技
已收盘 11-06 15:00:00
资讯
新帖
简况
药石科技:持续推进人工智能技术与药物研发及运营场景的融合应用
证券之星 · 11-04 20:53
药石科技:持续推进人工智能技术与药物研发及运营场景的融合应用
药石科技:公司聚焦CRDMO一体化服务
证券之星 · 11-04 20:53
药石科技:公司聚焦CRDMO一体化服务
药石科技(300725)11月3日主力资金净卖出737.68万元
证券之星 · 11-04
药石科技(300725)11月3日主力资金净卖出737.68万元
药石科技(300725)披露与专业投资机构共同投资暨参与私募股权投资基金的进展公告,11月03日股价下跌5.15%
证券之星 · 11-03
药石科技(300725)披露与专业投资机构共同投资暨参与私募股权投资基金的进展公告,11月03日股价下跌5.15%
药石科技(300725)10月9日股东户数4.39万户,较上期减少9.56%
证券之星 · 10-30
药石科技(300725)10月9日股东户数4.39万户,较上期减少9.56%
图解药石科技三季报:第三季度单季净利润同比增长26.60%
证券之星 · 10-30
图解药石科技三季报:第三季度单季净利润同比增长26.60%
药石科技(300725)10月28日主力资金净卖出506.92万元
证券之星 · 10-29
药石科技(300725)10月28日主力资金净卖出506.92万元
药石科技:南京CDMO创新基地项目正按照计划推进
证券之星 · 10-21
药石科技:南京CDMO创新基地项目正按照计划推进
药石科技(300725)10月9日股东户数4.39万户,较上期减少14.75%
证券之星 · 10-20
药石科技(300725)10月9日股东户数4.39万户,较上期减少14.75%
药石科技:截至2026年10月9日,公司股东人数43,893名
证券之星 · 10-20
药石科技:截至2026年10月9日,公司股东人数43,893名
药石科技(300725)10月16日主力资金净卖出117.50万元
证券之星 · 10-19
药石科技(300725)10月16日主力资金净卖出117.50万元
药石科技(300725)10月13日主力资金净卖出1367.22万元
证券之星 · 10-14
药石科技(300725)10月13日主力资金净卖出1367.22万元
10月8日药石科技跌6.54%,银河康乐股票A基金重仓该股
证券之星 · 10-08
10月8日药石科技跌6.54%,银河康乐股票A基金重仓该股
药石科技(300725)9月30日主力资金净买入7059.41万元
证券之星 · 10-08
药石科技(300725)9月30日主力资金净买入7059.41万元
9月30日药石科技涨5.97%,银河康乐股票A基金重仓该股
证券之星 · 09-30
9月30日药石科技涨5.97%,银河康乐股票A基金重仓该股
药石科技涨5.97%,开源证券一个月前给出“买入”评级
证券之星 · 09-30
药石科技涨5.97%,开源证券一个月前给出“买入”评级
药石科技(300725)9月24日主力资金净卖出2.49亿元
证券之星 · 09-28
药石科技(300725)9月24日主力资金净卖出2.49亿元
9月21日药石科技涨6.57%,银河康乐股票A基金重仓该股
证券之星 · 09-21
9月21日药石科技涨6.57%,银河康乐股票A基金重仓该股
药石科技涨6.57%,开源证券一个月前给出“买入”评级
证券之星 · 09-21
药石科技涨6.57%,开源证券一个月前给出“买入”评级
药石科技:截至2026年9月10日,公司股东人数51,488名
证券之星 · 09-16
药石科技:截至2026年9月10日,公司股东人数51,488名
加载更多
公司概况
公司名称:
南京药石科技股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2017-11-10
主营业务:
南京药石科技股份有限公司的主营业务是提供覆盖从早期药物发现到商业化生产的全流程服务。公司的主要产品是药物研究阶段的产品与服务、药物开发阶段的产品和服务、新分子实体(OPC)业务、绿色与智能技术平台。
发行价格:
11.32
{"stockData":{"symbol":"300725","market":"SZ","secType":"STK","nameCN":"药石科技","latestPrice":46.2,"timestamp":1793948604000,"preClose":47.96,"halted":0,"volume":20636381,"delay":0,"changeRate":-0.0367,"floatShares":202999999,"shares":234000000,"eps":0.9477,"marketStatus":"已收盘","change":-1.76,"latestTime":"11-06 15:00:00","open":45.45,"high":47.53,"low":45.42,"amount":960000000,"amplitude":0.044,"askPrice":46.21,"askSize":14,"bidPrice":46.2,"bidSize":118,"shortable":0,"etf":0,"ttmEps":0.9477,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":47.96,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":52.76,"lowLimit":43.16,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":233807341,"isCdr":false,"pbRate":2.44,"roa":"--","peRate":48.749604,"roe":"2.77%","epsLYR":0.88,"committee":0.750617,"marketValue":10802000000,"turnoverRate":0.1018,"status":1,"floatMarketCap":9366000000},"requestUrl":"/m/hq/s/300725","defaultTab":"news","newsList":[{"id":"2680051484","title":"药石科技:持续推进人工智能技术与药物研发及运营场景的融合应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2680051484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680051484?lang=zh_cn&edition=full","pubTime":"2026-11-04 20:53","pubTimestamp":1793796812,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技11月04日在投资者关系平台上答复投资者关心的问题。另外这个AI方面的布局,是只应用于公司内部嘛?目前,公司正推进统一数据平台、大模型及多智能体等相关能力建设,服务于药物发现、连续化制造、质量管理及运营等关键环节的效率提升。同时,公司依托ZoeStar AI药物发现平台,为客户提供相关药物发现服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400038876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229","161631"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680051928","title":"药石科技:公司聚焦CRDMO一体化服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2680051928","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680051928?lang=zh_cn&edition=full","pubTime":"2026-11-04 20:53","pubTimestamp":1793796810,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技11月04日在投资者关系平台上答复投资者关心的问题。公司战略聚焦于CRDMO一体化服务,业务重心也在持续向临床后期及商业化生产倾斜。公司将根据既定发展战略和业务实际推进相关业务布局,重大事项如达到信息披露标准,公司将及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400038873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680707254","title":"药石科技(300725)11月3日主力资金净卖出737.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680707254","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680707254?lang=zh_cn&edition=full","pubTime":"2026-11-04 10:18","pubTimestamp":1793758683,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月3日收盘,药石科技报收于42.92元,下跌5.15%,换手率11.82%,成交量23.97万手,成交额10.38亿元。近5日资金流向一览见下表:药石科技融资融券信息显示,融资方面,当日融资买入8525.85万元,融资偿还8640.14万元,融资净偿还114.29万元。药石科技主营业务:公司是全球生物医药领域以绿色与智能化学技术为核心的研发和制造一体化的创新服务供应商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400014655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680477937","title":"药石科技(300725)披露与专业投资机构共同投资暨参与私募股权投资基金的进展公告,11月03日股价下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680477937","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680477937?lang=zh_cn&edition=full","pubTime":"2026-11-03 19:06","pubTimestamp":1793704014,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘,药石科技报收于42.92元,较前一交易日下跌5.15%,最新总市值为100.35亿元。该股当日开盘44.82元,最高45.0元,最低42.5元,成交额达10.38亿元,换手率为11.82%。近日,南京药石科技股份有限公司发布《关于与专业投资机构共同投资暨参与私募股权投资基金的进展公告》。公告显示,公司作为有限合伙人认缴出资1500万元人民币,参与投资上海国弘医创智合创业投资合伙企业,占基金认缴出资总额的10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300037076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679158802","title":"药石科技(300725)10月9日股东户数4.39万户,较上期减少9.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679158802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679158802?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:27","pubTimestamp":1793359676,"startTime":"0","endTime":"0","summary":"证券之星消息,近日药石科技披露,截至2026年10月9日公司股东户数为4.39万户,较9月30日减少4641.0户,减幅为9.56%。在医疗服务行业个股中,药石科技股东户数低于行业平均水平,截至10月9日,医疗服务行业平均股东户数为4.99万户。从股价来看,2026年9月30日至2026年10月9日,药石科技区间跌幅为7.84%,在此期间股东户数减少4641.0户,减幅为9.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000047910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679643233","title":"图解药石科技三季报:第三季度单季净利润同比增长26.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679643233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679643233?lang=zh_cn&edition=full","pubTime":"2026-10-30 03:39","pubTimestamp":1793302758,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技2026年三季报显示,前三季度公司主营收入16.34亿元,同比上升15.16%;归母净利润1.51亿元,同比上升33.36%;扣非净利润1.28亿元,同比上升44.87%;其中2026年第三季度,公司单季度主营收入5.75亿元,同比上升15.1%;单季度归母净利润5177.13万元,同比上升26.6%;单季度扣非净利润4382.3万元,同比上升53.57%;负债率15.61%,投资收益1865.17万元,财务费用3177.55万元,毛利率32.93%。财报数据概要请见下图:本文数据来源于药石科技2026年三季报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000005864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679449001","title":"药石科技(300725)10月28日主力资金净卖出506.92万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679449001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679449001?lang=zh_cn&edition=full","pubTime":"2026-10-29 09:10","pubTimestamp":1793236255,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月28日收盘,药石科技报收于43.94元,上涨6.24%,换手率9.39%,成交量19.04万手,成交额8.22亿元。近5日资金流向一览见下表:药石科技融资融券信息显示,融资方面,当日融资买入5843.92万元,融资偿还8120.48万元,融资净偿还2276.56万元。药石科技主营业务:公司是全球生物医药领域以绿色与智能化学技术为核心的研发和制造一体化的创新服务供应商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900015930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677671749","title":"药石科技:南京CDMO创新基地项目正按照计划推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2677671749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677671749?lang=zh_cn&edition=full","pubTime":"2026-10-21 20:51","pubTimestamp":1792587088,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技10月20日在投资者关系平台上答复投资者关心的问题。同时能不能说明一下南京新CDMO基地的进展?谢谢药石科技回复:投资者您好,二级市场股价受宏观环境、行业发展及市场预期等多重因素影响。南京CDMO创新基地项目正按照计划推进,目前正在开展项目准入手续准备及专项团队组建等工作。后续如有达到信息披露标准的重大进展,公司将及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100039175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676696576","title":"药石科技(300725)10月9日股东户数4.39万户,较上期减少14.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676696576","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676696576?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:23","pubTimestamp":1792488209,"startTime":"0","endTime":"0","summary":"证券之星消息,近日药石科技披露,截至2026年10月9日公司股东户数为4.39万户,较9月10日减少7595.0户,减幅为14.75%。在医疗服务行业个股中,药石科技股东户数低于行业平均水平,截至10月9日,医疗服务行业平均股东户数为4.67万户。从股价来看,2026年9月10日至2026年10月9日,药石科技区间涨幅为20.31%,在此期间股东户数减少7595.0户,减幅为14.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000026252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676945663","title":"药石科技:截至2026年10月9日,公司股东人数43,893名","url":"https://stock-news.laohu8.com/highlight/detail?id=2676945663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676945663?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:12","pubTimestamp":1792483946,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技(300725)10月20日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2026年10月10日公司的股东人数是多少?谢谢药石科技回复:尊敬的投资者,您好!截至2026年10月9日,公司股东人数43,893名。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000023446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676657132","title":"药石科技(300725)10月16日主力资金净卖出117.50万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676657132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676657132?lang=zh_cn&edition=full","pubTime":"2026-10-19 09:16","pubTimestamp":1792372589,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月16日收盘,药石科技报收于44.03元,下跌3.1%,换手率13.82%,成交量28.03万手,成交额12.93亿元。近5日资金流向一览见下表:药石科技融资融券信息显示,融资方面,当日融资买入1.19亿元,融资偿还1.28亿元,融资净偿还890.51万元。药石科技主营业务:公司是全球生物医药领域以绿色与智能化学技术为核心的研发和制造一体化的创新服务供应商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900002555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675561399","title":"药石科技(300725)10月13日主力资金净卖出1367.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675561399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675561399?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:12","pubTimestamp":1791940342,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,药石科技报收于47.56元,下跌3.14%,换手率9.21%,成交量18.67万手,成交额8.77亿元。近5日资金流向一览见下表:药石科技融资融券信息显示,融资方面,当日融资买入6305.7万元,融资偿还8387.37万元,融资净偿还2081.67万元。药石科技主营业务:公司是全球生物医药领域以绿色与智能化学技术为核心的研发和制造一体化的创新服务供应商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400008297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673027139","title":"10月8日药石科技跌6.54%,银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673027139","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673027139?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:48","pubTimestamp":1791449324,"startTime":"0","endTime":"0","summary":"证券之星消息,10月8日药石科技跌6.54%,收盘报51.73元,换手率12.68%,成交量25.7万手,成交额13.58亿元。重仓药石科技的公募基金请见下表:该股最近90天内共有7家机构给出评级,买入评级5家,增持评级2家。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800021514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049236","title":"药石科技(300725)9月30日主力资金净买入7059.41万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049236","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049236?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:02","pubTimestamp":1791421374,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月30日收盘,药石科技报收于55.35元,上涨5.97%,换手率16.69%,成交量33.84万手,成交额18.76亿元。近5日资金流向一览见下表:药石科技融资融券信息显示,融资方面,当日融资买入1.46亿元,融资偿还1.57亿元,融资净偿还1071.24万元。药石科技主营业务:公司是全球生物医药领域以绿色与智能化学技术为核心的研发和制造一体化的创新服务供应商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671427289","title":"9月30日药石科技涨5.97%,银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671427289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671427289?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:39","pubTimestamp":1790757587,"startTime":"0","endTime":"0","summary":"证券之星消息,9月30日药石科技涨5.97%创60日新高,收盘报55.35元,换手率16.69%,成交量33.84万手,成交额18.76亿元。重仓药石科技的公募基金请见下表:该股最近90天内共有7家机构给出评级,买入评级5家,增持评级2家。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000026094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671009274","title":"药石科技涨5.97%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2671009274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671009274?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:39","pubTimestamp":1790757582,"startTime":"0","endTime":"0","summary":"今日药石科技涨5.97%,收盘报55.35元。2026年8月17日,开源证券研究员余汝意发布了对药石科技的研报《公司信息更新报告:盈利修复逐季验证,订单增长带来收入弹性》,该研报对药石科技给出“买入”评级。研报中预计2026-2028年公司归母净利润为2.49/3.34/4.12亿元,EPS为1.07/1.43/1.76元,当前股价对应PE为51.3/38.4/31.1倍,公司作为国内稀缺的CRDMO一体化平台,在手订单与项目管线持续积累支撑中长期成长,维持“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000026093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670240774","title":"药石科技(300725)9月24日主力资金净卖出2.49亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670240774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670240774?lang=zh_cn&edition=full","pubTime":"2026-09-28 09:24","pubTimestamp":1790558683,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月24日收盘,药石科技报收于52.08元,下跌4.18%,换手率13.94%,成交量28.26万手,成交额15.08亿元。近5日资金流向一览见下表:药石科技融资融券信息显示,融资方面,当日融资买入9901.8万元,融资偿还1.45亿元,融资净偿还4646.32万元。药石科技主营业务:公司是全球生物医药领域以绿色与智能化学技术为核心的研发和制造一体化的创新服务供应商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800002944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669416159","title":"9月21日药石科技涨6.57%,银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669416159","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669416159?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:46","pubTimestamp":1789980415,"startTime":"0","endTime":"0","summary":"证券之星消息,9月21日药石科技涨6.57%,收盘报50.32元,换手率13.78%,成交量27.93万手,成交额13.91亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.11亿元,最新净值2.344,较上一交易日上涨1.38%,近一年下跌14.2%。银河康乐股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159443","title":"药石科技涨6.57%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159443?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:46","pubTimestamp":1789980401,"startTime":"0","endTime":"0","summary":"今日药石科技涨6.57%,收盘报50.32元。2026年8月17日,开源证券研究员余汝意发布了对药石科技的研报《公司信息更新报告:盈利修复逐季验证,订单增长带来收入弹性》,该研报对药石科技给出“买入”评级。研报中预计2026-2028年公司归母净利润为2.49/3.34/4.12亿元,EPS为1.07/1.43/1.76元,当前股价对应PE为51.3/38.4/31.1倍,公司作为国内稀缺的CRDMO一体化平台,在手订单与项目管线持续积累支撑中长期成长,维持“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667855279","title":"药石科技:截至2026年9月10日,公司股东人数51,488名","url":"https://stock-news.laohu8.com/highlight/detail?id=2667855279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667855279?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:51","pubTimestamp":1789563075,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技09月15日在投资者关系平台上答复投资者关心的问题。截至2026年9月10日,公司股东人数51,488名。公司股票价格受行业环境、市场走势及投资者预期等多方面因素影响。互动易不属于法定信息披露渠道,关于股份减持、增发等事项,如有相关计划,公司将严格按照相关法律法规履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600035310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794030310143,"stockEarnings":[{"period":"1week","weight":0.0313},{"period":"1month","weight":-0.1653},{"period":"3month","weight":-0.0253},{"period":"6month","weight":0.2006},{"period":"1year","weight":0.1444},{"period":"ytd","weight":0.2112}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京药石科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"43893人(较上一季度减少9.56%)","perCapita":"4618股","listingDate":"2017-11-10","address":"江苏省南京市浦口区江北新区华盛路81号","registeredCapital":"23380万元","survey":" 南京药石科技股份有限公司的主营业务是提供覆盖从早期药物发现到商业化生产的全流程服务。公司的主要产品是药物研究阶段的产品与服务、药物开发阶段的产品和服务、新分子实体(OPC)业务、绿色与智能技术平台。","listedPrice":11.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药石科技(300725)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药石科技(300725)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药石科技,300725,药石科技股票,药石科技股票老虎,药石科技股票老虎国际,药石科技行情,药石科技股票行情,药石科技股价,药石科技股市,药石科技股票价格,药石科技股票交易,药石科技股票购买,药石科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药石科技(300725)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药石科技(300725)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}